About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The aim of our group is to investigate the use of medicines and evaluate its benefit/risk relationship in usual clinical practice. Our group coordinates the Catalan centre of the Spanish System of Pharmacovigilance. Research activities on pharmacology and pharmacoepidemiology are coupled with undergraduate teaching at the Autonomous University of Barcelona Medical School, training of specialists in clinical pharmacology, and continuous education of health professionals on therapeutics.
The group is a Special Group of Research recognized by AGAUR GenCat. It is a partner of “The European Consortium “EU PE&PV Network” (European Pharmacoepidemiology and Pharmacovigilance Network)” and it is part of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). It gives institutional support to the Clinical Research Ethical Committee of the University hospital Vall d’Hebron (UHVH), the Drug and Pharmacotherapeutic Committee of the UHVH, and also to the Drug and Pharmacotherapeutic Committee of the Institut Català de la Salut.
PMID: 34331263 Journal: INFECTION Year: 2022 Reference: Infection. 2022 Apr;50(2):371-380. doi: 10.1007/s15010-021-01662-1. Epub 2021 Jul 30. Impact factor: 3.553 Publication type: Paper in international publication Authors: Kirkegaard, Cristina, Falco-Roget, Anna, Sanchez-Montalva, Adrian, Valls, Angel, Clofent, David, Campos-Varela, Isabel, Garcia-Garcia, Sonia, Leguizamo, Lina Maria, Sellares-Nadal, Julia, Eremiev, Simeon et al. DOI: 10.1007/s15010-021-01662-1
PMID: 35078871 Journal: BMJ case reports Year: 2022 Reference: BMJ Case Rep. 2022 Jan 25;15(1). pii: 15/1/e244581. doi: 10.1136/bcr-2021-244581. Impact factor: 0 Publication type: Letter or abstract Authors: Anderssen-Nordahl, Emilie, Riera-Arnau, Judit, Perello Carrascosa, Manel, Gomez Munoz, Alicia et al. DOI: 10.1136/bcr-2021-244581
PMID: 35037981 Journal: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY Year: 2022 Reference: Eur J Clin Pharmacol. 2022 Apr;78(4):691-694. doi: 10.1007/s00228-022-03277-3. Epub 2022 Jan 17. Impact factor: 2.953 Publication type: Paper in international publication Authors: Belancic, Andrej, Sans-Pola, Carla, Jouanjus, Emilie, Alcubilla, Pau, Arellano, Ana Lucia, Nogueiras-Alvarez, Rita, Roncato, Rossana, Saez-Penataro, Joaquin, Zunic, Miodrag et al. DOI: 10.1007/s00228-022-03277-3
PMID: 34768461 Journal: Journal of Clinical Medicine Year: 2021 Reference: J Clin Med. 2021 Oct 26;10(21). pii: jcm10214941. doi: 10.3390/jcm10214941. Impact factor: 4.242 Publication type: Paper in international publication Authors: Sans-Pola, Carla, Agusti, Antonia, Bosch, Josep Angel, Agraz, Irene, Alerany, Carmen, Danes, Immaculada et al. DOI: 10.3390/jcm10214941
PMID: 34464214 Journal: Journal of Managed Care & Specialty Pharmacy Year: 2021 Reference: J Manag Care Spec Pharm. 2021 Sep;27(9):1210-1220. doi: 10.18553/jmcp.2021.27.9.1210. Impact factor: 2.903 Publication type: Paper in international publication Authors: Charlton, Alethea, Vidal, Xavier, Sabate, Monica, Bailarin, Elena, Martinez, Lina Maria Leguizamo, Ibanez, Luisa et al. DOI: 10.18553/jmcp.2021.27.9.1210
PMID: 34232478 Journal: CLINICAL DRUG INVESTIGATION Year: 2021 Reference: Clin Drug Investig. 2021 Aug;41(8):701-710. doi: 10.1007/s40261-021-01058-x. Epub 2021 Jul 7. Impact factor: 2.859 Publication type: Paper in international publication Authors: Jouanjus, Emilie, Sans-Pola, Carla, Mainoli, Beatrice, Javid, Farideh A, Ekheden, Isabella, Guillen, Elena, Freixo, Cristiana, Alcubilla, Pau, Mazhar, Faizan, Turner, Richard et al. DOI: 10.1007/s40261-021-01058-x
PMID: 34104210 Journal: Therapeutic Advances in Gastroenterology Year: 2021 Reference: Therap Adv Gastroenterol. 2021 May 30;14:17562848211016567. doi: 10.1177/17562848211016567. eCollection 2021. Impact factor: 4.409 Publication type: Paper in international publication Authors: Campos-Varela, Isabel, Villagrasa, Ares, Simon-Talero, Macarena, Riveiro-Barciela, Mar, Ventura-Cots, Meritxell, Aguilera-Castro, Lara, Alvarez-Lopez, Patricia, Nordahl, Emilie A, Rivera-Esteban, Jesus M, Romero, Alba et al. DOI: 10.1177/17562848211016567
The results show the need for continuous monitoring of patients to detect and manage possible adverse effects occurring months and years after treatment.
The creation of hybrid digital-human interaction spaces between avatars and people offers new opportunities for personalized medicine
The study by physician Emilie Anderssen seeks to optimize the medicalization of people living in nursing homes.
